{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:40:30Z","timestamp":1792006830781,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.tranon.2020.100914","type":"journal-article","created":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T18:34:54Z","timestamp":1604255694000},"page":"100914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Alpha-1 antitrypsin deficiency and risk of lung cancer: A systematic review"],"prefix":"10.1016","volume":"14","author":[{"given":"Ram\u00f3n A.","family":"Tub\u00edo-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6710-3766","authenticated-orcid":false,"given":"Mar\u00eda","family":"Torres-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7407-5249","authenticated-orcid":false,"given":"Alberto","family":"Fern\u00e1ndez-Villar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9927-7453","authenticated-orcid":false,"given":"Alberto","family":"Ruano-Ravi\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2020.100914_bib0001","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1172\/JCI113580","article-title":"Multiple tissues express alpha 1-antitrypsin in transgenic mice and man","volume":"82","author":"Carlson","year":"1988","journal-title":"J. Clin. Invest."},{"issue":"21","key":"10.1016\/j.tranon.2020.100914_bib0002","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1021\/bi00316a003","article-title":"Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant","volume":"23","author":"Long","year":"1984","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.tranon.2020.100914_bib0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/138920310790848368","article-title":"Genetic variants of alpha1-antitrypsin","volume":"11","author":"Salahuddin","year":"2010","journal-title":"Curr. Protein Pept. Sci."},{"issue":"4","key":"10.1016\/j.tranon.2020.100914_bib0004","first-page":"359","article-title":"Alpha1-antitrypsin: further genetic heterogeneity revealed by isoelectric focusing","volume":"30","author":"Kueppers","year":"1978","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tranon.2020.100914_bib0005","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2147\/COPD.S137852","article-title":"Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide","volume":"12","author":"Blanco","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.tranon.2020.100914_bib0006","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/COPD.S125389","article-title":"Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update","volume":"12","author":"Blanco","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"4","key":"10.1016\/j.tranon.2020.100914_bib0007","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/joim.12239","article-title":"Role of alpha-1 antitrypsin in human health and disease","volume":"276","author":"de Serres","year":"2014","journal-title":"J. Intern. Med."},{"issue":"Suppl C","key":"10.1016\/j.tranon.2020.100914_bib0008","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1053\/rmed.2000.0851","article-title":"Molecular mechanisms of alpha1-antitrypsin null alleles","volume":"94","author":"Lee","year":"2000","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.tranon.2020.100914_bib0009","doi-asserted-by":"crossref","first-page":"L179","DOI":"10.1152\/ajplung.00179.2014","article-title":"\u03b1-1-antitrypsin variants and the proteinase\/antiproteinase imbalance in chronic obstructive pulmonary disease","volume":"308","author":"Sinden","year":"2015","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"5","key":"10.1016\/j.tranon.2020.100914_bib0010","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1189\/jlb.0208145","article-title":"Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood","volume":"85","author":"Pott","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.tranon.2020.100914_bib0011","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/infdis\/jiu620","article-title":"Acute phase protein \u03b11-antitrypsin reduces the bacterial burden in mice by selective modulation of innate cell responses","volume":"211","author":"Kaner","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.tranon.2020.100914_bib0012","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0007-0971(83)90002-5","article-title":"Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British thoracic association","volume":"77","author":"Tobin","year":"1983","journal-title":"Br. J. Dis. Chest."},{"issue":"3","key":"10.1016\/j.tranon.2020.100914_bib0013","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40139-017-0147-5","article-title":"Liver disease in alpha-1 antitrypsin deficiency: current approaches and future directions","volume":"5","author":"Mitchell","year":"2017","journal-title":"Curr. Pathobiol. Rep."},{"issue":"10","key":"10.1016\/j.tranon.2020.100914_bib0014","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archinte.168.10.1097","article-title":"Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk","volume":"168","author":"Yang","year":"2008","journal-title":"Arch. Intern. Med."},{"issue":"7","key":"10.1016\/j.tranon.2020.100914_bib0015","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.arcmed.2006.05.006","article-title":"Association of moderate alpha-1 antitrypsin deficiency with lung cancer in the Serbian population","volume":"37","author":"Topic","year":"2006","journal-title":"Arch. Med. Res."},{"issue":"S2","key":"10.1016\/j.tranon.2020.100914_bib0016","doi-asserted-by":"crossref","DOI":"10.1186\/bcr1106","article-title":"Alpha-1 antitrypsin genotypes in breast cancer patients","volume":"7","author":"El-Akawi","year":"2005","journal-title":"Breast Cancer Res."},{"issue":"5","key":"10.1016\/j.tranon.2020.100914_bib0017","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/bjc.1984.90","article-title":"Alpha 1-antitrypsin levels and phenotypes and hepatitis B serology in liver cancer","volume":"49","author":"Sparos","year":"1984","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tranon.2020.100914_bib0018","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/1471-2407-14-355","article-title":"Serum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls","volume":"14","author":"P\u00e9rez-Holanda","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tranon.2020.100914_bib0019","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.tranon.2020.100914_bib0020","first-page":"461","article-title":"Alpha1-antitrypsin deficiency allele carriers among lung cancer patients","volume":"8","author":"Yang","year":"1999","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"4","key":"10.1016\/j.tranon.2020.100914_bib0021","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000154004","article-title":"Population genetics of alpha-1-antitrypsin polymorphism in US whites, US blacks and African blacks","volume":"41","author":"DeCroo","year":"1991","journal-title":"Hum. Hered."},{"issue":"9","key":"10.1016\/j.tranon.2020.100914_bib0022","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/JTO.0000000000000609","article-title":"Alpha-1 antitrypsin deficiency and lung cancer risk: a case-control study in never-smokers","volume":"10","author":"Torres-Dur\u00e1n","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"9","key":"10.1016\/j.tranon.2020.100914_bib0023","first-page":"3923","article-title":"SERPINA1 and ELA2 polymorphisms are not associated with COPD or lung cancer","volume":"32","author":"Enewold","year":"2012","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.tranon.2020.100914_bib0024","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/JTO.0b013e31820213fb","article-title":"Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival","volume":"6","author":"Li","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2020.100914_bib0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12931-019-1155-2","article-title":"Predictive value of a series of inflammatory markers in COPD for lung cancer diagnosis: a case-control study","volume":"20","author":"Mouronte-Roib\u00e1s","year":"2019","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.tranon.2020.100914_bib0026","first-page":"397","article-title":"Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting","volume":"75","year":"1997","journal-title":"Bull. World Health Organ."},{"issue":"5","key":"10.1016\/j.tranon.2020.100914_bib0027","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1034\/j.1399-0004.2003.00143.x","article-title":"Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia\/New Zealand: australia, Canada, New Zealand and the United States of America","volume":"64","author":"de Serres","year":"2003","journal-title":"Clin. Genet."},{"issue":"2","key":"10.1016\/j.tranon.2020.100914_bib0028","first-page":"181","article-title":"Relationship between alpha-;1 antitrypsin deficient genotypes S and Z and lung cancer in Jordanian lung cancer patients","volume":"27","author":"El-;Akawi","year":"2006","journal-title":"Saudi Med. J."},{"issue":"3","key":"10.1016\/j.tranon.2020.100914_bib0029","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1470-2045(04)01414-7","article-title":"Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression","volume":"5","author":"Sun","year":"2004","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2020.100914_bib0030","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1183\/09031936.05.00021605","article-title":"alpha1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants","volume":"26","author":"Senn","year":"2005","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.tranon.2020.100914_bib0031","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.canlet.2016.09.002","article-title":"COPD, emphysema and the onset of lung cancer","volume":"382","author":"Mouronte-Roib\u00e1s","year":"2016","journal-title":"Syst. Rev. Cancer Lett."},{"issue":"4","key":"10.1016\/j.tranon.2020.100914_bib0032","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/ijc.2910450419","article-title":"Alpha 1-antitrypsin and survival in pancreatic cancer","volume":"45","author":"Trichopoulos","year":"1990","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2020.100914_bib0033","first-page":"482","article-title":"Alpha-1 antitrypsin (alpha1-AT) plasma levels in lung, prostate and breast cancer patients","volume":"29","author":"El-Akawi","year":"2008","journal-title":"Neuro Endocrinol. Lett."},{"issue":"2","key":"10.1016\/j.tranon.2020.100914_bib0034","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12253-016-0104-3","article-title":"Alpha-1-antitrypsin antagonizes cisplatin-induced cytotoxicity in prostate cancer (PC3) and melanoma cancer (A375) cell lines","volume":"23","author":"Ljujic","year":"2017","journal-title":"Pathol. Oncol. Res. POR"},{"issue":"10","key":"10.1016\/j.tranon.2020.100914_bib0035","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.jtho.2016.05.021","article-title":"The international epidemiology of lung cancer: latest trends, disparities, and tumor characteristics","volume":"11","author":"Cheng","year":"2016","journal-title":"J. Thorac. Oncol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652332030406X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652332030406X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:44:41Z","timestamp":1761835481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193652332030406X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S193652332030406X"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2020.100914","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpha-1 antitrypsin deficiency and risk of lung cancer: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2020.100914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100914"}}